We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+18.24%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30B
AUM Growth
+$2.64B
(+9.6%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
36.32%
Top 10 Holdings %
Top 10 Hldgs %
9.49%
Holding
835
New
69
Increased
208
Reduced
338
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13B |
| 2 |
Citigroup
C
|
+$151M |
| 3 |
AXIS Capital
AXS
|
+$135M |
| 4 |
RTX Corp
RTX
|
+$123M |
| 5 |
Edison International
EIX
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Cisco
CSCO
|
+$112M |
| 3 |
Honeywell
HON
|
+$97.8M |
| 4 |
UnitedHealth
UNH
|
+$92.6M |
| 5 |
Citizens Financial Group
CFG
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.12% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 13.47% |
| 4 | Industrials | 11.75% |
| 5 | Consumer Discretionary | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
351
DELISTED
Audentes Therapeutics, Inc
BOLD
| $25.6M | 0.09% |
657,131
+224,573
| +52% | +$6.44M |
|
352
First Solar
FSLR
$21.4B
| $25.4M | 0.08% |
+481,345
| New | +$24.2M |
|
|
STL
353
DELISTED
Sterling Bancorp
STL
| $25.4M | 0.08% |
1,363,028
+351,396
| +35% | +$6.72M |
|
354
ITT
ITT
$17.1B
| $25.2M | 0.08% |
433,731
+112,800
| +35% | +$6.16M |
|
355
Advanced Micro Devices
AMD
$700B
| $25M | 0.08% |
978,871
+718,176
| +275% | +$16.3M |
|
356
Paychex
PAYX
$43.4B
| $24.8M | 0.08% |
+308,800
| New | +$22.8M |
|
357
General Dynamics
GD
$103B
| $24.5M | 0.08% |
145,000
-10,818
| -7% | -$1.82M |
|
358
Gentex
GNTX
$5.1B
| $24.5M | 0.08% |
1,186,000
-414,600
| -26% | -$8.67M |
|
359
Tactile Systems Technology
TCMD
$618M
| $24.4M | 0.08% |
462,320
+214,253
| +86% | +$13.8M |
|
360
Universal Display
OLED
$3.75B
| $24.2M | 0.08% |
158,614
+110,180
| +227% | +$13.6M |
|
361
Dentsply Sirona
XRAY
$2.84B
| $24.2M | 0.08% |
+488,580
| New | +$21.5M |
|
362
Gilead Sciences
GILD
$165B
| $24.1M | 0.08% |
371,488
+47,600
| +15% | +$3.16M |
|
363
Nasdaq
NDAQ
$53.4B
| $24.1M | 0.08% |
825,600
+230,700
| +39% | +$6.57M |
|
364
Exelixis
EXEL
$13.9B
| $24M | 0.08% |
+1,007,275
| New | +$23M |
|
|
VIAB
365
DELISTED
Viacom Inc. Class B
VIAB
| $23.7M | 0.08% |
843,200
-130,200
| -13% | -$3.74M |
|
366
Illumina
ILMN
$29.5B
| $23.6M | 0.08% |
78,229
-175,576
| -69% | -$51.2M |
|
367
Entergy
ETR
$50.3B
| $23.6M | 0.08% |
492,724
+24,400
| +5% | +$1.1M |
|
|
NEE.PRR
368
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $23.3M | 0.08% |
377,220
-173,948
| -32% | -$10.4M |
|
|
PLAN
369
DELISTED
Anaplan, Inc.
PLAN
| $23.3M | 0.08% |
591,360
-11,737
| -2% | -$395K |
|
370
First Industrial Realty Trust
FR
$8.66B
| $22.9M | 0.08% |
647,515
| – | – |
|
|
NVRO
371
DELISTED
NEVRO CORP.
NVRO
| $22.7M | 0.08% |
+363,360
| New | +$17.1M |
|
372
FMC
FMC
$1.25B
| $22.6M | 0.08% |
294,334
+25,045
| +9% | +$1.84M |
|
373
Omnicom Group
OMC
$22.7B
| $22.3M | 0.07% |
306,081
+94,896
| +45% | +$7.13M |
|
374
Conagra Brands
CAG
$7.42B
| $22.3M | 0.07% |
803,001
+198,429
| +33% | +$4.55M |
|
|
AZPN
375
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $22.2M | 0.07% |
+213,364
| New | +$22.2M |
|
Similar funds
Lord, Abbett & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Lord, Abbett & Co held 835 positions worth $30B, up 9.6% from $27.4B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Lord, Abbett & Co deployed $10.9B of net new capital in Q1 2019, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 12,559,121 shares worth $69.1M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $146M trimmed.
- Lord, Abbett & Co's largest Q1 2019 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 12,559,121 shares worth $69.1M.
- Lord, Abbett & Co added most to Citigroup in Q1 2019, an estimated $151M increase.
- Lord, Abbett & Co's biggest Q1 2019 reduction was Microsoft, cutting an estimated $146M.
- Lord, Abbett & Co fully exited UnitedHealth in Q1 2019, selling an estimated $92.6M.
- Lord, Abbett & Co's ten largest holdings make up 9.5% of its $30B portfolio in Q1 2019.
- Lord, Abbett & Co opened 69 new positions and closed 135 in Q1 2019.
- Lord, Abbett & Co's portfolio value rose 9.6% quarter-over-quarter to $30B.
Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.